BeStock  

Mesa Laboratories MLAB

US equityMarket cap rank #3367Scientific & Technical Instruments
$127.93 −$5.48 (-4.11%)
Market closed · Nov 20, 8:20 pm ET · Last extended-hours $127.93 0.00%
Open$131.62
Prev close$133.41
Day range$126.73 – $134.00
Volume76.0K
Market cap$719.03M
P/E (TTM)110.3
Dividend yield0.50%

Fundamentals

Latest reported quarter: Q2, ended Sep 2026

Revenue$62.34M+2.6% YoY
Operating profit$8.39M+77.6% YoY
Net profit$4.34M+75.3% YoY
Diluted EPS$0.75+66.7% YoY
Free cash flow$3.71M-48.0% YoY
Operating cash flow$4.10M

Revenue, last 8 quarters

$62.8MDec '24$62.1MMar '25$59.5MJun '25$60.7MSep '25$65.1MDec '25$63.7MMar '26$60.1MJun '26$62.3MSep '26

Net profit, last 8 quarters

$-1.7MDec '24$-7.1MMar '25$4.7MJun '25$2.5MSep '25$3.6MDec '25$-4.1MMar '26$2.8MJun '26$4.3MSep '26

Diluted EPS by quarter

-0.31Dec '24-1.31Mar '250.85Jun '250.45Sep '250.65Dec '25-0.75Mar '260.49Jun '260.75Sep '26

Free cash flow by quarter

$17.3MDec '24$11.7MMar '25$884.0KJun '25$7.1MSep '25$18.0MDec '25$13.5MMar '26$14.2MJun '26$3.7MSep '26

Annual revenue

$133.9MFY21$184.3MFY22$219.1MFY23$216.2MFY24$241.0MFY25$249.1MFY26

Profitability & balance sheet

Gross margin64.8%
Operating margin10.4%
Net margin2.7%
Return on equity3.6%
Return on assets1.6%
Return on invested capital3.7%
Current ratio1.90
Liabilities / assets52.3%
Cash & investments$22.31M
Total debt$131.51M
Net cash (debt)-$109.19M
Free cash flow / sales19.7%

Where the revenue comes from

Quarter 2027/Q2

By business line

  • Sterilization and Disinfection Control$25.34M 40.7%
  • Calibration Solutions$14.05M 22.5%
  • Biopharmaceutical Development$12.78M 20.5%
  • Clinical Genomics$10.17M 16.3%

Income statement

Line item 2027 Q2 2027 Q1 2026 ANNUAL 2026 Q4 2026 Q3
Total Revenue as Reported $62.34M $60.14M $249.13M $63.72M $65.13M
Total Operating Revenue $62.34M $60.14M $249.13M $63.72M $65.13M
Cost of Revenue $22.46M $21.13M $90.86M $21.52M $23.33M
Gross Profit $39.88M $39.01M $158.27M $42.21M $41.80M
Operating Expense $31.49M $31.98M $139.76M $39.46M $33.82M
Selling and Admin Expenses $26.44M $27.26M $119.45M $34.21M $28.79M
-Selling & Marketing Expense $9.83M $9.87M $40.79M $10.08M $9.99M
-General & Admin Expense $16.61M $17.38M $78.66M $24.13M $18.81M
Research & Development $5.05M $4.73M $20.31M $5.25M $5.03M
Operating Profit $8.39M $7.03M $18.51M $2.75M $7.98M
Net Non-Operating Interest Income (Expense) -$2.14M -$2.36M -$10.69M -$2.60M -$3.04M
Non-Operating Interest Expense $2.14M $2.36M $10.69M $2.60M $3.04M
Other Income (Expense) -$217,000.00 -$315,000.00 $4.20M -$1.75M -$343,000.00
Other Non-Operating Income (Expenses) -$217,000.00 -$315,000.00 $4.20M -$1.75M -$343,000.00
Pretax Profit $6.03M $4.35M $12.01M -$1.59M $4.60M
Tax $1.69M $1.52M $5.30M $2.54M $966,000.00
Net Profit $4.34M $2.83M $6.71M -$4.14M $3.63M
Profit from Continuing Operations $4.34M $2.83M $6.71M -$4.14M $3.63M
Net Income to Parent Company $4.34M $2.83M $6.71M -$4.14M $3.63M
Net Income to Common Stockholders $4.34M $2.83M $6.71M -$4.14M $3.63M
Basic EPS $0.77 $0.50 $1.22 -$0.75 $0.66
Diluted EPS $0.75 $0.49 $1.21 -$0.75 $0.65
Dividend Per Share $0.16 $0.16 $0.64 $0.16 $0.16
Special Income (Charges) – – $0.00 $0.00 $0.00
-Less:Impairment of Capital Assets – – $0.00 – –

Balance sheet

Line item 2027 Q2 2027 Q1 2026 ANNUAL 2026 Q4 2026 Q3
Total Assets $407.74M $419.22M $427.75M $427.75M $434.85M
Total Current Assets $98.25M $102.85M $106.27M $106.27M $105.63M
Cash and Cash Equivalents & Short-Term Investments $22.31M $30.70M $26.93M $26.93M $28.98M
-Cash and Cash Equivalents $22.31M $30.70M $26.93M $26.93M $28.98M
Receivables $39.38M $34.41M $44.10M $44.10M $40.23M
-Accounts Receivable $39.38M $34.41M $44.10M $44.10M $40.23M
Prepaid Assets $5.13M $6.04M $5.25M $5.25M $5.93M
Inventory $26.55M $27.23M $26.37M $26.37M $26.56M
Other Current Assets $4.88M $4.48M $3.62M $3.62M $3.93M
Total Non-Current Assets $309.49M $316.38M $321.48M $321.48M $329.22M
Net PPE $29.35M $30.09M $30.61M $30.61M $31.60M
-Gross PPE $60.96M $61.20M $60.73M $60.73M $61.50M
-Accumulated Depreciation -$31.61M -$31.11M -$30.12M -$30.12M -$29.90M
Goodwill and Other Intangible Assets $258.75M $264.44M $270.21M $270.21M $278.95M
-Goodwill $185.24M $186.04M $186.86M $186.86M $189.30M
-Other Intangible Assets $73.51M $78.40M $83.35M $83.35M $89.65M
Non-Current Deferred Assets $1.49M $1.49M $1.50M $1.50M $1.47M
Other Non-Current Assets $19.91M $20.36M $19.16M $19.16M $17.20M
Total Liabilities $213.14M $230.46M $241.50M $241.50M $248.16M
Total Current Liabilities $51.58M $57.32M $61.90M $61.90M $54.40M
Payables $27.50M $32.28M $35.63M $35.63M $28.35M
-Accounts Payable $4.82M $7.46M $4.93M $4.93M $5.25M
-Total Tax Payable $12.74M $14.58M $14.01M $14.01M $11.53M
-Other Payable $9.93M $10.24M $16.69M $16.69M $11.58M
Current Accrued Expenses $2.21M $2.27M $2.23M $2.23M $2.44M
Short-Term Debt and Capital Lease Obligation $7.87M $8.26M $9.31M $9.31M $9.05M
-Current Debt $5.63M $5.63M $5.63M $5.63M $5.16M
-Current Capital Lease Obligation $2.24M $2.63M $3.69M $3.69M $3.89M
Current Deferred Liabilities $14.01M $14.52M $14.72M $14.72M $14.56M
Total Non-Current Liabilities $161.56M $173.14M $179.60M $179.60M $193.76M
Long Term Debt and Capital Lease Obligation $125.88M $137.24M $145.86M $145.86M $171.93M
-Long Term Debt $125.88M $137.24M $145.86M $145.86M $160.97M
Non-Current Deferred Liabilities $19.92M $20.05M $20.09M $20.09M $21.83M
Other Non-Current Liabilities $15.75M $15.85M $13.66M $13.66M –
Total Equity $194.60M $188.76M $186.25M $186.25M $186.69M
Stockholders' Equity $194.60M $188.76M $186.25M $186.25M $186.69M
Capital Stock $380.13M $376.75M $375.35M $375.35M $368.56M
-Common Stock $380.13M $376.75M $375.35M $375.35M $368.56M
Retained Earnings -$180.36M -$183.80M -$185.75M -$185.75M -$180.73M
Gains/Losses Not Affecting Retained Earnings -$5.17M -$4.19M -$3.36M -$3.36M -$1.14M
-Long Term Capital Lease Obligation – – – – $10.96M

Cash flow

Line item 2027 Q2 2027 Q1 2026 ANNUAL 2026 Q4 2026 Q3
Operating Cash Flow $4.10M $14.74M $42.83M $13.96M $18.75M
Net cash flow from continuing operations $4.10M $14.74M $42.83M $13.96M $18.75M
Net Income from Continuing Operations $4.34M $2.83M $6.71M -$4.14M $3.63M
Gain/Loss from Continuing Operations $149,000.00 $354,000.00 – – $281,000.00
Depreciation & Depletion & Amortization $5.56M $5.65M $23.27M $5.75M $5.72M
Other Non-Cash Items $738,000.00 $623,000.00 $1.26M -$2.88M $1.26M
Change in Working Capital -$10.07M $2.93M -$4.99M $3.93M $4.48M
-Change in Receivables -$5.10M $9.78M -$3.21M -$4.13M -$819,000.00
-Change in Inventory -$298,000.00 -$1.53M -$4.43M -$974,000.00 $596,000.00
-Change in Prepaid Assets $204,000.00 -$2.28M $608,000.00 $2.15M -$715,000.00
-Change in Payables and Accrued Expense -$4.38M -$2.87M $2.30M $6.62M $5.18M
-Change In Other Working Capital -$498,000.00 -$171,000.00 -$255,000.00 $259,000.00 $244,000.00
Net cash flow from investing -$387,000.00 -$559,000.00 -$3.25M -$417,000.00 -$732,000.00
Net Cash Flow from Continuing Investing Activities -$387,000.00 -$559,000.00 -$3.25M -$417,000.00 -$732,000.00
Net PPE Purchase and Sale -$387,000.00 -$559,000.00 -$3.25M -$417,000.00 -$732,000.00
Financing Cash Flow -$12.31M -$10.50M -$41.85M -$15.76M -$9.79M
Net Cash Flow from Continuing Financing Activities -$12.31M -$10.50M -$41.85M -$15.76M -$9.79M
Net Issuance Payments Of Debt -$11.41M -$8.66M -$26.75M -$14.69M -$8.69M
Cash Dividends Paid -$898,000.00 -$884,000.00 -$3.52M -$884,000.00 -$884,000.00
Net Other Financing Charges -$10,000.00 -$958,000.00 -$11.58M -$188,000.00 -$214,000.00
Ending Cash Balance $22.31M $30.70M $26.93M $26.93M $28.98M
Net Change in Cash -$8.61M $3.68M -$2.27M -$2.21M $8.24M
Beginning Cash Balance $30.70M $26.93M $27.32M $28.98M $20.42M
Effect of Exchange Rate Changes $222,000.00 $88,000.00 $1.88M $167,000.00 $316,000.00
Free Cash Flow $3.71M $14.18M $39.58M $13.55M $18.02M
Deferred Tax – – -$1.29M – –
Net Intangibles Purchase and Sale – – $0.00 – –
Net Business Purchase and Sale – – $0.00 – –
Proceeds from Stock Option Exercised – – $0.00 – –

Discussion

No comments yet — be the first to weigh in on MLAB.

Sign in to join the discussion.

Scroll to Top